Key Takeaways from the CDDF Multi-Stakeholder Workshop on Clinical Research in Central and Eastern Europe (15 April 2024, Krakow)
The first day of the CDDF workshop on Clinical Research in Central and Eastern Europe brought together a diverse group of stakeholders to facilitate dialogue and collaboration. Here are the key takeaways from Day 1's program: SESSION 1: CURRENT STATUS OF...
Gain Valuable Perspectives from Participants of the CDDF Annual Conference and Get an Inside Look at Its Multi-Stakeholder Discussions (Feb 2024)
View the CDDF’s interviews with participants at the CDDF Annual Conference 2024 (5 – 7 February 2024, Noordwijk) and gain valuable perspectives on key topics in oncology from diverse stakeholders. https://youtu.be/4LezZVWhgZM Continued dialogue and collaboration is...
[ 🔔 📣 NEW PUBLICATION: EXECUTIVE SUMMARY OF THE CDDF ANNUAL CONFERENCE 2024] The Cancer Drug Development Forum (CDDF) is delighted to announced that its executive summary of this year’s Annual Conference has been published today and is available to all our...
Key Takeaways from the CDDF Webinar on Clinical Research in Central and Eastern Europe
The Cancer Drug Development Forum (CDDF) held a live webinar on “Clinical Research in Central and Eastern Europe, Realising the opportunities “ on Monday 12 February 2024 at 17:00 (CET) / 11:00 (EST). In this webinar, Susan Bhatti (Merck BV, NL), Mark Lawler (Queen’s...
CDDF Annual Conference 2024 – Key Takeaways from Session 3: Decentralized Care and Trials
The second day of the CDDF Annual Conference 2024 brought multi-stakeholder speakers and audience together to facilitate candid dialogue on important topics in oncology. Here are the key takeaways from Session 3: Decentralized Care and Trials: 🔶 The Covid-19 pandemic...
CDDF Annual Conference 2024 – Key Takeaways from Session 1: Real World Evidence
The first day of the CDDF Annual Conference 2024 generated highly productive and vibrant dialogue around critical questions about real world evidence and underscoring the importance of collaborative efforts. Here are the key takeaways from Session 1: Real World...